Caribou Biosciences (CRBU) Other Working Capital Changes (2020 - 2025)
Caribou Biosciences has reported Other Working Capital Changes over the past 6 years, most recently at -$1.2 million for Q4 2025.
- Quarterly Other Working Capital Changes fell 146.16% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.7 million through Dec 2025, down 948.73% year-over-year, with the annual reading at -$3.7 million for FY2025, 948.73% down from the prior year.
- Other Working Capital Changes was -$1.2 million for Q4 2025 at Caribou Biosciences, down from -$627000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $30.0 million in Q1 2021 and troughed at -$30.7 million in Q4 2021.
- The 5-year median for Other Working Capital Changes is -$738000.0 (2025), against an average of -$1.3 million.
- The largest YoY upside for Other Working Capital Changes was 3383.26% in 2021 against a maximum downside of 3191.63% in 2021.
- A 5-year view of Other Working Capital Changes shows it stood at -$30.7 million in 2021, then skyrocketed by 78.95% to -$6.5 million in 2022, then crashed by 157.89% to -$16.7 million in 2023, then soared by 115.65% to $2.6 million in 2024, then plummeted by 146.16% to -$1.2 million in 2025.
- Per Business Quant, the three most recent readings for CRBU's Other Working Capital Changes are -$1.2 million (Q4 2025), -$627000.0 (Q3 2025), and -$849000.0 (Q2 2025).